Automated Organization ProfileDepartment of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand
Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets in this organization
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the organization's datasets
Total Mentions
Total mentions of the organization's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 3.2 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
S1 Fig. The high-pressure liquid chromatography-electrospray ionisation-mass spectroscopic (HPLC-ESI-MS) chromatogram of C. gigantea stem bark extracts (CGEtOAc) in negative mode.S2 Fig. The IC50 curves for (A) CGEtOAc and (B) sorafenib in HepG2 cells, and (C) CGEtOAc in IMR-90 cells for 24 h of incubation.S3 Fig. The combination index (CI) vs. fraction affected (Fa) graph for CGEtOAc in combination with sorafenib after 24 h of incubation.S4 Fig. The migration rate of HepG2 cells treated with CGEtOAc at 400 µg/mL and sorafenib at 4 µM, both singly and in combination, was evaluated using a wound healing assay after 0-72 h of incubation and compared to the vehicle group. S5 Raw images displaying the gating strategies used in flow cytometry of annexin V and propidium iodide (PI) staining in HepG2 cells after 24 h of incubation, with a combination of 400 µg/mL CGEtOAc and 4 µM sorafenib.S6 Raw images of the original uncropped and unadjusted western blot images for HepG2 cells treated with a combination of 400 µg/mL CGEtOAc and 4 µM sorafenib for a 24-h incubation period.
Authors
- Chaisupasakul, Pattaraporn ;
- Pekthong, Dumrongsak ;
- Wangteeraprasert, Apirath ;
- KAEWKONG, WORASAK ;
- Somran, Julintorn ;
- Kaewpaeng, Naphat ;
- Parhira, Supawadee ;
- SRISAWANG, PIYARAT
S1 Fig. The high-pressure liquid chromatography-electrospray ionisation-mass spectroscopic (HPLC-ESI-MS) chromatogram of C. gigantea stem bark extracts (CGEtOAc) in negative mode.S2 Fig. The IC50 curves for (A) CGEtOAc and (B) sorafenib in HepG2 cells, and (C) CGEtOAc in IMR-90 cells for 24 h of incubation.S3 Fig. The combination index (CI) vs. fraction affected (Fa) graph for CGEtOAc in combination with sorafenib after 24 h of incubation.S4 Fig. The migration rate of HepG2 cells treated with CGEtOAc at 400 µg/mL and sorafenib at 4 µM, both singly and in combination, was evaluated using a wound healing assay after 0-72 h of incubation and compared to the vehicle group. S5 Raw images displaying the gating strategies used in flow cytometry of annexin V and propidium iodide (PI) staining in HepG2 cells after 24 h of incubation, with a combination of 400 µg/mL CGEtOAc and 4 µM sorafenib.S6 Raw images of the original uncropped and unadjusted western blot images for HepG2 cells treated with a combination of 400 µg/mL CGEtOAc and 4 µM sorafenib for a 24-h incubation period.
Authors
- Chaisupasakul, Pattaraporn ;
- Pekthong, Dumrongsak ;
- Wangteeraprasert, Apirath ;
- KAEWKONG, WORASAK ;
- Somran, Julintorn ;
- Kaewpaeng, Naphat ;
- Parhira, Supawadee ;
- SRISAWANG, PIYARAT